ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå ¿¹Ãø(-2030³â) : Áö¿ªº° ºÐ¼® - À¯Çüº°, Á¦Ç°º°, ±â¼úº°, ³Ã» À¯Çüº°, ȯÀÚ À¯Çüº°, ÆÇ¸Å ä³Îº°
North America Hearing Aids Market Forecast to 2030 - Regional Analysis - by Type, Product Type, Technology, Type Of Hearing Loss, Patient Type, and Distribution Channel
ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº 2022³â 102¾ï 2,281¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2030³â¿¡´Â 154¾ï 5,297¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2022-2030³â°£ ¿¬Æò±Õ 5.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.
û·Â ¼Õ½Ç ¹ß»ý·ü Áõ°¡·Î ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå ¼ºÀå ÃËÁø
û·Â ¼Õ½ÇÀº ½ÅüÀû, Á¤¼Àû, Á¤½ÅÀû °Ç° µî Àΰ£ °æÇèÀÇ ¸ðµç Ãø¸é¿¡ ±íÀº ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀÌ ¿¬·É´ë´Â ³Ã» À§ÇèÀÌ ³ô±â ¶§¹®¿¡ ³ëÀÎ Àα¸ Áõ°¡´Â ³Ã» ȯÀÚ ¼ö Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é 2020³â Àü ¼¼°è 60¼¼ ÀÌ»ó ³ëÀÎ Àα¸´Â 10¾ï ¸í¿¡ À°¹ÚÇϰí 2030³â ¸»¿¡´Â 14¾ï ¸í, 2050³â¿¡´Â 21¾ï ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³â¿¡´Â Àü ¼¼°è Àα¸ÀÇ ¾à 5%(4¾ï3200¸¸ ¸í)°¡ ³Ã»¿¡ ´ëóÇϱâ À§ÇÑ ÀçȰÀÌ ÇÊ¿äÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀçȰÀÌ ÇÊ¿äÇϸç, 2050³â ¸»¿¡´Â 7¾ï ¸í ÀÌ»ó¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. û·Â ¼Õ½ÇÀº ³ë³âÃþ¿¡¼ ¸¹ÀÌ ¹ß»ýÇÏÁö¸¸ ¸ðµç ¿¬·É´ëÀÇ »ç¶÷µéÀÌ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. °úµµÇÑ ¼ÒÀ½ ³ëÃâÀº ¼ö¹é¸¸ ¸íÀÇ ³²³à³ë¼Ò¿¡°Ô û·Â ¼Õ½ÇÀ» ÀÏÀ¸Å°´Â ÁÖ¿ä ¿øÀÎ Áß ÇϳªÀÔ´Ï´Ù. ´Ü±â°£ÀÇ ¼ÒÀ½ ³ëÃâÀ̳ª ¹Ýº¹ÀûÀÎ ¼ÒÀ½ ³ëÃâÀº ³»ÀÌ¿¡ ¿µ±¸ÀûÀÎ ¼Õ»óÀ» ÀÔÇô ¿µ±¸ÀûÀÎ ³Ã»À» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ½Ã²ô·¯¿î ȯ°æ¿¡¼ ÀÏÇÏ´Â »ç¶÷µé¿¡°Ô´Â ´õ Å« À§ÇèÀÌ ÀÖ½À´Ï´Ù. ¹Ì±¹ û·Â ¼Õ½Ç Çùȸ(HLAA)ÀÇ 'û·Â ¼Õ½Ç »ç½Ç°ú Åë°è(Hearing Loss Facts and Statistics)'¿¡ µû¸£¸é, ¹Ì±¹¿¡¼´Â ¿¬°£ 2,200¸¸ ¸íÀÇ ±Ù·ÎÀÚ°¡ Á÷Àå¿¡¼ À§ÇèÇÑ ¼ÒÀ½¿¡ ³ëÃâµÇ¾î ÀÖ´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ ÀÌ ÀÚ·á¿¡ µû¸£¸é ¹Ì±¹ ³²¼º 5¸í Áß 1¸í, ¿©¼º 8¸í Áß 1¸íÀÌ Ã»·Â Àå¾Ö¸¦ È£¼ÒÇϰí ÀÖ´Ù°í ÇÕ´Ï´Ù. ³Ã»À» ¹æÄ¡ÇÏ¸é ½Ã°£ÀÌ Áö³²¿¡ µû¶ó ¾Ç鵃 ¼ö ÀÖ½À´Ï´Ù. º¸Ã»±â´Â û·Â ¼Õ½Ç·Î ÀÎÇØ ¼Õ½ÇµÇ°Å³ª °¨¼Ò µÈ û°¢ ÀÚ±ØÀ» Á¦°øÇÔÀ¸·Î½á °³ÀÎÀÇ »îÀÇ ÁúÀ» Å©°Ô Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ Àüü ¶Ç´Â ºÎºÐ ³Ã» À¯º´·ü Áõ°¡´Â Àα¸ Áß º¸Ã»±â ¼ö¿ä¸¦ Áõ°¡½ÃŰ´Â Áß¿äÇÑ ¿äÀÎÀ¸·Î º¸Ã»±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå °³¿ä
National Institute on Deafness and Other Communication Disorders¿¡ µû¸£¸é, 2021³â¿¡´Â ¹Ì±¹ 12¼¼ ÀÌ»ó Àα¸ÀÇ 13%ÀÎ 3,000¸¸ ¸íÀÌ ÇÑÂÊ ¶Ç´Â ¾çÂÊ ±ÍÀÇ ³Ã»À» °æÇèÇÏ°Ô µÉ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ÀÌ ÀÚ·á¿¡ µû¸£¸é, ¹Ì±¹¿¡¼´Â 2,880¸¸ ¸íÀÌ º¸Ã»±âÀÇ ÇýÅÃÀ» ¹ÞÀ» ¼ö ÀÖ´Ù°í ÇÕ´Ï´Ù. ¹Ì±¹¿¡´Â Á¦Ç° °³¹ß ¹× Ãâ½Ã¿¡ ÁÖ·ÂÇϰí ÀÖ´Â ½ÅÈï ½ÃÀå ¼±µµ ±â¾÷µéÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ FDAÀÇ OTC º¸Ã»±â ½ÂÀÎÀº ½ÃÀå¿¡ ÃæºÐÇÑ ±âȸ¸¦ °¡Á®¿Ã °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023³â 10¿ùAudien HearingÀº ¼¼°è ÃÖÃÊÀÇ FDA Áؼö OTC º¸Ã»±â ATOM ONEÀ» 100 ´Þ·¯ ÀÌÇÏÀÇ °¡°ÝÀ¸·Î Ãâ½ÃÇß½À´Ï´Ù. 2023³â 10¿ù, AI ±â¹Ý º¸Ã»±â ¹× ¿Àµð¿À ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ELEHEAR´Â ù ¹øÂ° OTC º¸Ã»±âÀÎ ELEHEAR Alpha¿Í ELEHEAR Alpha Pro¸¦ Ãâ½ÃÇß½À´Ï´Ù. ¹ßÇ¥Çß½À´Ï´Ù. µû¶ó¼ ´ë±Ô¸ð Àα¸ÀÇ Ã»·Â Àå¾Ö À¯º´·ü Áõ°¡, ½ÅÁ¦Ç° Ãâ½Ã ¹× °æÁ¦ÀûÀÎ °¡°ÝÀ¸·Î ½ÃÆÇµÇ´Â º¸Ã»±âÀÇ °¡¿ë¼ºÀº ¹Ì±¹ ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÕ´Ï´Ù.
ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå ¸ÅÃâ ¹× 2030³â±îÁöÀÇ ¿¹Ãø(±Ý¾×)
ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå ¼¼ºÐÈ
ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº À¯Çü, Á¦Ç° À¯Çü, ±â¼ú, ³Ã» À¯Çü, ȯÀÚ À¯Çü, À¯Åë ä³Î ¹× ±¹°¡º°·Î ºÐ·ùµË´Ï´Ù. À¯Çüº°·Î ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº ó¹æÀü º¸Ã»±â¿Í ÀÏ¹Ý º¸Ã»±â·Î ³ª´µ¸ç, 2022³â¿¡´Â ó¹æÀü º¸Ã»±â ºÎ¹®ÀÌ ´õ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Á¦Ç° À¯Çüº°·Î ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº º¸Ã»±â ÀåÄ¡¿Í º¸Ã»±â ÀÓÇöõÆ®·Î ³ª´µ¸ç, º¸Ã»±â ÀåÄ¡ ºÎ¹®ÀÌ 2022³â ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ º¸Ã»±â ÀåÄ¡ ºÎ¹®Àº ±Í¿¡ Âø¿ëÇÏ´Â(BTE) º¸Ã»±â, ±Í¿¡ Âø¿ëÇÏ´Â(ITE) º¸Ã»±â, ±Í¿¡ Âø¿ëÇÏ´Â(RITE) º¸Ã»±â, ¿îÇÏ º¸Ã»±â ¹× ±âŸ·Î ¼¼ºÐȵ˴ϴÙ. ¶ÇÇÑ º¸Ã»±â ÀÓÇöõÆ® ºÎ¹®Àº Àΰø ¿Í¿ì¿Í °ñÀüµµ ÀÓÇöõÆ®·Î ³ª´¹´Ï´Ù.
±â¼úº°·Î ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº ±âÁ¸ º¸Ã»±â¿Í µðÁöÅÐ º¸Ã»±â·Î ³ª´µ¸ç, 2022³â ½ÃÀå Á¡À¯À²Àº ±âÁ¸ º¸Ã»±â°¡ ´õ Å®´Ï´Ù.
û·Â ¼Õ½Ç À¯Çüº°·Î ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº °¨À½¼º ³Ã»°ú ÀüÀ½¼º ³Ã»À¸·Î ³ª´¹´Ï´Ù. 2022³â¿¡´Â °¨À½¼º ³Ã» ºÎ¹®ÀÌ Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ȯÀÚ À¯Çüº°·Î ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº ¼ºÀΰú ¼Ò¾Æ·Î ³ª´µ¸ç, 2022³â ½ÃÀå Á¡À¯À²Àº ¼ºÀÎÀÌ ´õ Ŭ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº À¯Åë ä³Î¿¡ µû¶ó ¾à±¹, ¼Ò¸ÅÁ¡ ¹× ¿Â¶óÀÎÀ¸·Î ±¸ºÐµË´Ï´Ù. ¾à±¹ ºÎ¹®ÀÌ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
±¹°¡º°·Î ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµÇ¸ç, 2022³â ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå Á¡À¯À²Àº ¹Ì±¹ÀÌ µ¶Â÷ÁöÇß½À´Ï´Ù.
Starkey Laboratories Inc., Audina Hearing Instruments Inc., Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, Amplifon Hearing Health Care Corp. µîÀÌ ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå¿¡¼ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷µéÀÔ´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
- Á¶»ç ¹üÀ§
- 2Â÷ Á¶»ç
- 1Â÷ Á¶»ç
Á¦4Àå ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå - ÁÖ¿ä »ê¾÷ ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- ÇâÈÄ µ¿Çâ
- ¿µÇ⠺м®
Á¦5Àå º¸Ã»±â ½ÃÀå : ºÏ¹Ì ½ÃÀå ºÐ¼®
- ¼·Ð
- ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå ÆÇ¸Å·®, 2022-2030³â
Á¦6Àå ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå - 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø : À¯Çüº°
- ½ÃÀå °³¿ä
- º¸Ã»±â ½ÃÀå : 2022³â°ú 2030³â À¯Çüº° ÆÇ¸Å Á¡À¯À²(%)
- ó¹æ º¸Ã»±â
- ½ÃÆÇ º¸Ã»±â
Á¦7Àå ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå : 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø : Á¦Ç° À¯Çüº°
- ¼·Ð
- º¸Ã»±â ½ÃÀå : 2022³â°ú 2030³â Á¦Ç° À¯Çüº° ÆÇ¸Å Á¡À¯À²(%)
- º¸Ã»±â µð¹ÙÀ̽º
- º¸Ã»±â ÀÓÇöõÆ®
Á¦8Àå ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå : 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø : ±â¼úº°
- ¼·Ð
- º¸Ã»±â ½ÃÀå : 2022³â°ú 2030³â ±â¼úº° ÆÇ¸Å Á¡À¯À²(%)
- ±âÁ¸ º¸Ã»±â
- µðÁöÅÐ º¸Ã»±â
Á¦9Àå ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå : 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø : ³Ã» À¯Çüº°
- ¼·Ð
- º¸Ã»±â ½ÃÀå : 2022³â°ú 2030³â ³Ã» À¯Çüº° ÆÇ¸Å Á¡À¯À²(%)
- °¨À½¼º ³Ã»
- ÀüÀ½¼º ³Ã»
Á¦10Àå ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå : 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø : ȯÀÚ À¯Çüº°
- ¼·Ð
- º¸Ã»±â ½ÃÀå : 2022³â°ú 2030³â ȯÀÚ À¯Çüº° ÆÇ¸Å Á¡À¯À²(%)
- ¼ºÀÎ
- ¼Ò¾Æ
Á¦11Àå ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå : 2030³â±îÁö ¸ÅÃâ°ú ¿¹Ãø : À¯Åë ä³Îº°
- ¼·Ð
- º¸Ã»±â ½ÃÀå : 2022³â°ú 2030³â À¯Åë ä³Îº° ÆÇ¸Å Á¡À¯À²(%)
- ¾à±¹
- ¼Ò¸ÅÁ¡
- ¿Â¶óÀÎ
Á¦12Àå ºÏ¹ÌÀÇ º¸Ã»±â ½ÃÀå : ±¹°¡º° ºÐ¼®
Á¦13Àå ¾÷°è »óȲ
- ¼·Ð
- ¿À°¡´Ð µ¿Çâ
- ¹«±âÀû Àü°³
Á¦14Àå ±â¾÷ °³¿ä
- Starkey Laboratories Inc
- Audina Hearing Instruments Inc
- SeboTek Hearing Systems LLC
- Earlens Corp
- GN Store Nord AS
- Cochlear Ltd
- WS Audiology AS
- Sonova Holding AG
- Sonic Innovations Inc
- Amplifon Hearing Health Care Corp
Á¦15Àå ºÎ·Ï
LSH
The North America hearing aids market was valued at US$ 10,222.81 million in 2022 and is expected to reach US$ 15,452.97 million by 2030; it is estimated to register a CAGR of 5.3% from 2022 to 2030.
Rising Incidence of Hearing Loss Fuels North America Hearing Aids Market
Hearing loss profoundly impacts every dimension of the human experience, including physical, emotional, and mental health. The rising geriatric population contributes to the growing number of people with hearing loss, as the risk of hearing loss is higher in this age group. According to the World Health Organization (WHO), there were nearly 1 billion people in 2020 aged 60 years and above globally, which is expected to reach 1.4 billion by the end of 2030 and is projected to reach 2.1 billion by 2050. As per WHO, ~5% of the global population (432 million people) will require rehabilitation to address their hearing loss in 2023, which is expected to reach over 700 million by the end of 2050. Although hearing loss is more common among aged people, people of all ages can be affected. Exposure to excessive noise is one of the leading causes of hearing loss for millions of young and old Americans. Both short-term and repeated noise exposure can cause lasting damage to the inner ear, resulting in permanent hearing loss. It's a particular risk for people working around loud noises. According to the Hearing Loss Association of America (HLAA), Hearing Loss Facts and Statistics, ~22 million US workers are exposed to dangerous noise levels in their workplaces yearly. The same source further stated that one out of five men and one of eight women in the country report hearing trouble. When left untreated, hearing loss can worsen with time. Hearing aids can significantly improve an individual's quality of life by providing auditory stimuli that could have been lost or reduced due to loss of hearing. Thus, the rising prevalence of hearing loss, wholly or partially, is a key factor boosting the demand for hearing aid devices among the population, thereby driving the growth of the hearing aids market.
North America Hearing Aids Market Overview
As per the National Institute on Deafness and Other Communication Disorders, ~30 million people or 13% of the US population aged 12 years and above was experiencing hearing loss in one or both ears in 2021. As per the same source, ~28.8 million people in the US could benefit from the use of hearing aids. Country has presence of the leading global market players, which are focused on product development and launches. Furthermore, FDA approval for OTC hearing aids is expected to create ample opportunities in the market. In October 2023, Audien Hearing launched the world's first FDA-compliant hearing aid sold over-the-counter (OTC)-ATOM ONE-for less than US$ 100. The ATOM ONE would allow millions of people suffering from hearing loss to walk in and purchase an economical device suiting their or their loved ones' needs. In October 2023, ELEHEAR, a provider of AI-powered hearing aids and audio solutions, introduced its first OTC hearing aid devices-the ELEHEAR Alpha and ELEHEAR Alpha Pro. Therefore, increasing prevalence of hearing impairment among large populations, new product launches, and availability of OTC hearing aids at economical pricing favors the market growth in the US.
North America Hearing Aids Market Revenue and Forecast to 2030 (US$ Million)
North America Hearing Aids Market Segmentation
The North America hearing aids market is segmented based on type, product type, technology, type of hearing loss, patient type, distribution channel, and country. Based on type, the North America hearing aids market is bifurcated into prescription hearing aids and OTC hearing aids. The prescription hearing aids segment held a larger market share in 2022.
In terms of product type, the North America hearing aids market is bifurcated into hearing aid devices and hearing implants. The hearing aid devices segment held a larger market share in 2022. Furthermore, the hearing aid devices segment is subsegmented into behind-the-ear (BTE) hearing aid, in-the-ear (ITE) hearing aid, receiver-in-the-ear (RITE) hearing aid, canal hearing aid, and others. Additionally, the hearing implants segment is bifurcated into cochlear implants and bone conduction implants.
By technology, the North America hearing aids market is bifurcated into conventional hearing aids and digital hearing aids. The conventional hearing aids segment held a larger market share in 2022.
Based on type of hearing loss, the North America hearing aids market is bifurcated into sensorineural hearing loss and conductive hearing loss. The sensorineural hearing loss segment held a larger market share in 2022.
Based on patient type, the North America hearing aids market is bifurcated into adults and pediatric. The adults segment held a larger market share in 2022.
Based on distribution channel, the North America hearing aids market is segmented into pharmacies, retail stores, and online. The pharmacies segment held the largest market share in 2022.
Based on country, the North America hearing aids market is segmented into the US, Canada, and Mexico. The US dominated the North America hearing aids market share in 2022.
Starkey Laboratories Inc., Audina Hearing Instruments Inc, Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, and Amplifon Hearing Health Care Corp. are some of the leading companies operating in the North America hearing aids market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Hearing Aids Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Incidence of Hearing Loss
- 4.1.2 Growing Strategic Initiatives by the Companies
- 4.2 Market Restraints
- 4.2.1 High Cost of Customized and Prescribed Hearing Aids
- 4.3 Market Opportunities
- 4.3.1 Approval of Over-The-Counter Hearing Aids
- 4.4 Future Trends
- 4.4.1 Technological Innovations in Hearing Aids
- 4.5 Impact Analysis
5. Hearing Aids Market - North America Market Analysis
- 5.1 Overview
- 5.2 North America Hearing Aids Market Revenue (US$ Mn), 2022 - 2030
6. North America Hearing Aids Market - Revenue and Forecast to 2030 - by Type
- 6.1 Overview
- 6.2 North America Hearing Aids Market Revenue Share, by Type 2022 & 2030 (%)
- 6.3 Prescription Hearing Aids
- 6.3.1 Overview
- 6.3.2 Prescription Hearing Aids: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4 OTC Hearing Aids
- 6.4.1 Overview
- 6.4.2 OTC Hearing Aids: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Hearing Aids Market - Revenue and Forecast to 2030 - by Product Type
- 7.1 Overview
- 7.2 Hearing Aids Market Revenue Share, by Product Type 2022 & 2030 (%)
- 7.3 Hearing Aid Devices
- 7.3.1 Overview
- 7.3.2 Hearing Aid Devices: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.2.1 Hearing Aids Market - Hearing Aid Devices Revenue and Forecast to 2030 (US$ Million)
- 7.4 Hearing Implants
- 7.4.1 Overview
- 7.4.2 Hearing Implants: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.2.1 Hearing Aids Market - Hearing Implants Revenue and Forecast to 2030 (US$ Million)
8. North America Hearing Aids Market - Revenue and Forecast to 2030 - by Technology
- 8.1 Overview
- 8.2 Hearing Aids Market Revenue Share, by Technology 2022 & 2030 (%)
- 8.3 Conventional Hearing Aids
- 8.3.1 Overview
- 8.3.2 Conventional Hearing Aids: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Digital Hearing Aids
- 8.4.1 Overview
- 8.4.2 Digital Hearing Aids: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Hearing Aids Market - Revenue and Forecast to 2030 - by Type of Hearing Loss
- 9.1 Overview
- 9.2 Hearing Aids Market Revenue Share, by Type of Hearing Loss 2022 & 2030 (%)
- 9.3 Sensorineural Hearing Loss
- 9.3.1 Overview
- 9.3.2 Sensorineural Hearing Loss: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Conductive Hearing Loss
- 9.4.1 Overview
- 9.4.2 Conductive Hearing Loss: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Hearing Aids Market - Revenue and Forecast to 2030 - by Patient Type
- 10.1 Overview
- 10.2 Hearing Aids Market Revenue Share, by Patient Type 2022 & 2030 (%)
- 10.3 Adults
- 10.3.1 Overview
- 10.3.2 Adults: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Pediatrics
- 10.4.1 Overview
- 10.4.2 Pediatrics: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
11. North America Hearing Aids Market - Revenue and Forecast to 2030 - by Distribution Channel
- 11.1 Overview
- 11.2 Hearing Aids Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
- 11.3 Pharmacies
- 11.3.1 Overview
- 11.3.2 Pharmacies: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
- 11.4 Retail Stores
- 11.4.1 Overview
- 11.4.2 Retail Stores: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
- 11.5 Online
- 11.5.1 Overview
- 11.5.2 Online: Hearing Aids Market - Revenue and Forecast to 2030 (US$ Million)
12. North America Hearing Aids Market - Country Analysis
- 12.1 North America Hearing Aids Market, Revenue and Forecast to 2030
- 12.1.1 North America Hearing Aids Market, by Country
- 12.1.1.1 US
- 12.1.1.1.1 Overview
- 12.1.1.1.2 US Hearing Aids Market Revenue and Forecast to 2030 (US$ Mn)
- 12.1.1.1.3 US: Hearing Aids Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.1.4 US: Hearing Aids Market, by Product Type, 2020-2030 (US$ Million)
- 12.1.1.1.4.1 US: Hearing Aids Market, by Hearing Aid Devices for Product Type, 2020-2030 (US$ Million)
- 12.1.1.1.4.2 US: Hearing Aids Market, by Hearing Implants for Product Type, 2020-2030 (US$ Million)
- 12.1.1.1.5 US: Hearing Aids Market, by Technology, 2020-2030 (US$ Million)
- 12.1.1.1.6 US: Hearing Aids Market, by Type of Hearing Loss, 2020-2030 (US$ Million)
- 12.1.1.1.7 US: Hearing Aids Market, by Patient Type, 2020-2030 (US$ Million)
- 12.1.1.1.8 US: Hearing Aids Market, by Distribution Channel, 2020-2030 (US$ Million)
- 12.1.1.2 Canada
- 12.1.1.2.1 Overview
- 12.1.1.2.2 Canada Hearing Aids Market Revenue and Forecast to 2030 (US$ Mn)
- 12.1.1.2.3 Canada: Hearing Aids Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.2.4 Canada: Hearing Aids Market, by Product Type, 2020-2030 (US$ Million)
- 12.1.1.2.4.1 Canada: Hearing Aids Market, by Hearing Aid Devices for Product Type, 2020-2030 (US$ Million)
- 12.1.1.2.4.2 Canada: Hearing Aids Market, by Hearing Implants for Product Type, 2020-2030 (US$ Million)
- 12.1.1.2.5 Canada: Hearing Aids Market, by Technology, 2020-2030 (US$ Million)
- 12.1.1.2.6 Canada: Hearing Aids Market, by Type of Hearing Loss, 2020-2030 (US$ Million)
- 12.1.1.2.7 Canada: Hearing Aids Market, by Patient Type, 2020-2030 (US$ Million)
- 12.1.1.2.8 Canada: Hearing Aids Market, by Distribution Channel, 2020-2030 (US$ Million)
- 12.1.1.3 Mexico
- 12.1.1.3.1 Overview
- 12.1.1.3.2 Mexico Hearing Aids Market Revenue and Forecast to 2030 (US$ Mn)
- 12.1.1.3.3 Mexico: Hearing Aids Market, by Type, 2020-2030 (US$ Million)
- 12.1.1.3.4 Mexico: Hearing Aids Market, by Product Type, 2020-2030 (US$ Million)
- 12.1.1.3.4.1 Mexico: Hearing Aids Market, by Hearing Aid Devices for Product Type, 2020-2030 (US$ Million)
- 12.1.1.3.4.2 Mexico: Hearing Aids Market, by Hearing Implants for Product Type, 2020-2030 (US$ Million)
- 12.1.1.3.5 Mexico: Hearing Aids Market, by Technology, 2020-2030 (US$ Million)
- 12.1.1.3.6 Mexico: Hearing Aids Market, by Type of Hearing Loss, 2020-2030 (US$ Million)
- 12.1.1.3.7 Mexico: Hearing Aids Market, by Patient Type, 2020-2030 (US$ Million)
- 12.1.1.3.8 Mexico: Hearing Aids Market, by Distribution Channel, 2020-2030 (US$ Million)
13. Industry Landscape
- 13.1 Overview
- 13.2 Organic Developments
- 13.3 Inorganic Developments
14. Company Profiles
- 14.1 Starkey Laboratories Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 Audina Hearing Instruments Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 SeboTek Hearing Systems LLC
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Earlens Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Development
- 14.5 GN Store Nord AS
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 Cochlear Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 WS Audiology AS
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
- 14.8 Sonova Holding AG
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Sonic Innovations Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
- 14.10 Amplifon Hearing Health Care Corp
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
- 15.1 About Us
- 15.2 Glossary of Terms